insights_auto
Why is ARGX down 4.09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€727.60
arrow_downward
-4.09%(-31.00) 1D
Oct 16, 5:39:35 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€759.20
High
€761.80
Low
€727.60
Mkt. cap
48.36B
Avg. vol.
86.90K
Volume
96.25K
P/E ratio
30.95
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.51
Shares outstanding
35.93M
No. of employees
2K
Open
€759.20
High
€761.80
Low
€727.60
Mkt. cap
48.36B
Avg. vol.
86.90K
Volume
96.25K
P/E ratio
30.95
52-wk high
€925.00
52-wk low
€568.40
EPS
€23.51
Shares outstanding
35.93M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
2 hours ago
argenx reports trial results: what it means for argenx stock
TipRanks
·
13 hours ago
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
22 hours ago
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
1 day ago
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE